SkinBioTherapeutics COO Simon Hewitson is to step away from the company on personal grounds.

The AIM-listed life science company, which is focused on skin health, said recruitment for his successor has commenced.

In the meantime, his duties are being managed by Stuart Ashman, CEO, and Emily Bertram, group finance director.